Traws Pharma, Inc. (TRAW)
NASDAQ: TRAW · Real-Time Price · USD
1.640
-0.020 (-1.20%)
At close: Apr 2, 2026, 4:00 PM EDT
1.720
+0.080 (4.88%)
After-hours: Apr 2, 2026, 7:49 PM EDT
Traws Pharma Market Cap
Traws Pharma has a market cap or net worth of $13.11 million as of April 2, 2026. Its market cap has decreased by -6.00% in one year.
Market Cap
13.11M
Enterprise Value
6.69M
1-Year Change
-6.00%
Ranking
Category
Stock Price
$1.64
Market Cap Chart
Since July 25, 2013, Traws Pharma's market cap has decreased from $409.28M to $13.11M, a decrease of -96.80%. That is a compound annual growth rate of -23.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 13.11M | 45.13% |
| Dec 31, 2025 | 9.03M | -72.02% |
| Dec 31, 2024 | 32.27M | 106.05% |
| Dec 29, 2023 | 15.66M | 15.90% |
| Dec 30, 2022 | 13.51M | -74.64% |
| Dec 31, 2021 | 53.27M | -38.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Phio Pharmaceuticals | 14.87M |
| Intensity Therapeutics | 14.48M |
| GT Biopharma | 14.18M |
| IN8bio | 14.18M |
| OSR Holdings | 14.11M |
| BioCardia | 13.13M |
| Jupiter Neurosciences | 12.69M |
| Quoin Pharmaceuticals | 12.66M |